Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-26

Clinical Trial Update: Phase I Study With V-212 Vaccinations in Healthy Adult Volunteers [EARLY_Phase 1]

View source ↗

Summary

Phase I clinical trial update for the V-212 vaccination in healthy adult volunteers to immunize against pneumococcal disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • V-212 vaccine

Snippet

Sponsor: Virometix | Conditions: Healthy, Immunisation Against Streptococcus Pneumoniae | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING